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There is a high rate of medication non-adherence, which can lead to disease progression, disability and 
mortality. This study tested a novel computer-based text message reminder system to improve adherence 
to medications. This system proved effective in improving adherence to a placebo in healthy volunteers, 
and to medications in cardiac patients over a two month period. It was especially effective in individuals at 
prospectively identified to be at high risk of non-adherence. This system represents a simple and scalable 
method to improve adherence to medications at a clinical or pharmaceutical level. Further research into 
the impact of repeated reminders is necessary to explore the impacts of text message reminders in other 
populations and in other lifestyle interventions.
Il y a un taux élevé de non-adhérence aux médicaments, ce qui peut provoquer la progression de la maladie, 
des handicaps et même la mortalité. Cette étude a vérifier un système de rappel fonctionnant par messagerie 
texte afin d’améliorer l’adhérence aux médicaments. Ce système a été prouvé efficace dans l’amélioration de 
l’adhérence à un placébo chez des sujets bénévoles, et à des médicaments chez des patients cardiaques, sur 
une période de 2 mois. Il était particulièrement efficace chez es individus identifiés comme ayant un risque 
élevé de non-adhérence. Ce système représente une méthode simple et mesurable utilisée pour améliorer 
l’adhérence aux médicaments à un niveau pharmaceutique ou clinique. Des recherches plus poussées sur 
les conséquences de ces rappels répétés sont nécessaires afin d’explorer les impacts des rappels texte chez 
d’autres populations et dans d’autres interventions concernant les habitudes de vie.
BACKGROUND
Medication non-adherence or non-compliance is 
defined as erroneous methods of taking medication, 
whether at the incorrect quantity, or incorrect time 
as prescribed.1,3,4,5 This can limit the effectiveness 
of medications, lead to disease progression, and in 
some extreme cases, can lead to premature death. 5, 
6 Studies suggest that non-adherence to medications 
is extremely prevalent in our society. 1- 6 
Non-adherence to medication is categorized into 
two main groups: intentional and non-intentional.7 
Intentional non-adherence can include deliberately 
choosing not to take medications due to personal 
preference, not understanding or believing in the 
importance of the medication or choosing not to take 
the medication due to perceived side effects.7 Non-
intentional non-adherence occurs where the individual 
is not deliberately refusing to take medications, but 
may be making medication errors unintentionally due 
to factors like complexity of medication regimens, 
inability to acquire or administer the medication or 
forgetting to take the medication.7 
Studies have identified forgetfulness as a leading 
cause of medication non-adherence.4, 6, 7 Although 
systems exist today to reduce non-adherence, few 
focus on reducing forgetfulness.3, 4 Those systems 
that do address forgetfulness often are only able to 
address one part of forgetfulness; beepers remind 
patients to take medications but don’t inform them of 
what medications to take. Pill boxes help patients to 
take the correct medications, but don’t remind them 
to take them. In addition, because carrying these 
systems on one’s person is cumbersome, they are 
often left at home, reducing their effectiveness.3,4 
Certain populations like the elderly, those with 
cognitive or neurological diseases like stroke, 
dementia and depression, as well as those with 
lower educational levels have been shown to be 
at greater risk for medication non adherence.1,3,5,8 
Available systems like pill boxes, blister packs and 
beepers have had limited success at reducing non-
adherence (only 5-20% relative risk reduction). 4-6 
An effective solution to this clinical problem has 
yet to be determined4. A more effective, automated 
system of reminders could be used to help reduce 
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forgetfulness induced non-adherence to medication. 
This study tests the feasibility and the efficacy of 
a novel, computerized, automated text message 
(SMS) system to decrease non-adherence to 
placebos and medications. 
METHODS:
Design:
This was a single center, pre- / post- intervention 
study of medication adherence using SMS reminders. 
There were three phases to this study. 
Phase 1: Technology pilot 
Phase 2: Pilot testing in volunteers
Phase 3: Real World Intervention
The study comprised of three phases with two initial 
pilot phases to ensure feasibility and technical 
reliability of the technology, and its ability to improve 
adherence to a placebo, and then a real world 
assessment involving volunteer Cardiac patients 
from a community cardiology clinic using their own 
medications on their own regimen.
Ethics: 
 A test protocol, & written informed consent form were 
reviewed by Dr. S. Sykes, University of Waterloo 
Human Research Ethics Board. We obtained written 
informed consent from all participants before any 
procedures were carried out.
Setting:
This study was carried out in the cities of Waterloo 
(pop. 100 000) and Cambridge (pop. 150 000), Ontario. 
Recruitment of four volunteers to test the reliability of the 
system took place in the city of Waterloo. Recruitment 
of 25 healthy volunteers for a pilot test also took place 
in Waterloo. 30 cardiac patients were recruited at 
Cambridge Cardiac Care (a community cardiology clinic 
serving Waterloo Region: pop. 550 000).
Population and Subject Selection:
In phases one and two, the populations studied were 
healthy volunteers. All participants were adults who 
had cell phones. In phase three, the population was 
volunteers from a Canadian cardiology community 
practice (Cambridge Cardiac Care Centre). Study 
population size was determined for phase three through 
power analysis of phase two data. We included all stable 
cardiac patients above 18 years of age, who were able 
to read and write English and competent to provide 
informed consent. Children, those without a cell phone, 
those unable to read and write in English, those unable 
to provide informed consent, those unable to comply 
with study protocol and incarcerated individuals were 
excluded from the study.
Phase One: Intervention and Technology Pilot: 
In phase one, we created a computer program to 
send text messages to cell phones using Microsoft 
Visual Basic 2008 Express Edition. The automated 
text message reminder system checks the time every 
minute, until it reaches a specific time when a patient 
is supposed to take a medication. The system sends 
an email to a web portal, which converts the email 
to a text message and sends it to the patient’s cell 
phone. Text messages were sent four times daily to 
4 volunteers with different cell phones and different 
cell phone providers over two months, to validate the 
stability and reliability of this system.
PHASE TWO: PILOT TEST:
Twenty-five healthy volunteers were recruited to 
test this model. Demographic information was 
obtained on all volunteers: age, gender, education 
level, cell phone number, and cell phone provider. 
The test procedure involved self-reported removal 
of a placebo (a raisin) from vials. Individuals had 
to remove and discard a raisin at 7:30 am, 12 pm, 
6:00 pm, and 9:00 pm. Volunteers were randomized, 
using a web based random number generator (http://
www.randomnumbergenerator.com), to receive text 
message reminders in either week one or week 
two. For one week, individuals removed the placebo 
raisins without any reminders. For a second week, 
they received reminder text messages & had to 
record whether they received the text message & 
whether they removed the raisin. Volunteers recorded 
removal of raisins & receipt of text messages in 
specially prepared and supplied logbooks. Half of the 
subjects began receiving text message reminders for 
the first week, and received no text message for the 
second week, while the other half of subjects did not 
received text message reminders in the first week, 
and received text message reminders in the second 
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week. Adherence was determined by measuring 
the number of total prescribed doses of raisins, and 
the number of doses of raisins actually removed as 
recorded in log books. Total overall accuracy of self-
reported placebo removal was determined through 
a “pill count” of returned vials of raisins. Individuals 
had been randomized to receive text messages 
either in week one or week two to mitigate a potential 
trainer effect bias, which is a bias introduced by being 
exposed to a specific task and becoming familiar 
with the task such that it influences the result of a 
subsequent intervention being investigated.9 
PHASE THREE: REAL WORLD VALIDATION
Thirty random volunteers from a local cardiology 
practice were recruited. A nurse at this facility was 
contacted, and patients were recruited under her 
supervision. Written informed consent was obtained. 
Demographic information was obtained on all 
volunteers. Volunteer were asked to take their own 
medications at their own prescribed regimen for one 
month and record their adherence in a specially 
designed logbook. For a second month, they 
received reminder text messages & had to record 
their adherence according to their own prescribed 
regimen. The percent adherence was determined 
by dividing the medications taken by the medication 
prescribed. Half of the subjects were randomized to 
receive text message reminders for the first month, 
and received no text message for the second month, 
while the other half of subjects were randomized not 
to receive text message reminders in the first month, 
and to receive text message reminders in the second 
month to eliminate any potential trainer effect.
DATA ANALYSIS
We performed three main types of analysis: absolute 
risk reduction, relative risk reduction, and subgroup 
analysis. Adherence was determined from patient 
medication logs by calculating the number of total 
prescribed doses, and measuring the number of 
doses actually taken as recorded in log books.9 
Absolute risk reduction was determined by comparing 
average adherence of individuals receiving reminders 
to that of individuals not receiving reminders. Relative 
risk reduction was determined by dividing absolute 
risk reduction by the control incidence rate (non-
adherence in the individuals not receiving reminders). 
Certain groups, chosen prospectively according 
to literature review, were identified as having a 
greater risk of medication regimen non-adherence 
(elderly, less than grade 12 education, patients with 
depression, and dementia). Adherence, and risk 
reduction for these groups was compared to that of 
the total study population.
Statistical Analysis:
We used GraphPad Instat 3.10 to perform statistical 
analysis. We used paired Students T-test for 
comparisons of two variables because the same 
subjects were used for each period of time and 
served as their own controls. We used ANOVA with 
Bonferroni correction test (for multiple comparisons) 
for comparisons with two or more variables. A p-value 
of 0.05 was considered statistically significant.
RESULTS:
DISCUSSION: 
Based on the work of Choudhry et al. in 2011, absolute 
increases in adherence of over 5% can be considered 
a clinically significant improvement. In a population of 
stable cardiac patients, this study demonstrated on 
average 11% absolute improvement in medication 
adherence, suggesting this system may have a 
meaningful clinical impact. This is in accordance with 
the work of Friedman et al. 1996, which demonstrated 
Phase One:
In the first phase of our study, our feasibility pilot, our four 
healthy volunteers received and logged 100% of text messages 
sent. We verified each text message reminder logged by the 
volunteers with an email audit trail. All messages were sent in 
a timely and accurate fashion.
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Table 1: Phase Two - Pilot Test Phase Two: 
Table 1 shows the results from the cohort study in Phase Two. A 
high rate of medication non-adherence to placebo regimen was 
noted in healthy volunteers (35%). Improvements in adherence 
with this text message reminder system were consistent, with 
an average absolute improvement of 20%, with a relative risk 
reduction for non-adherence of 65%. Text message reminders 
were reliably sent from an automated computer program and 
were effective at improving adherence in all groups studied. 
Adherence was determined using self-recorded log books. 
This is the method routinely used in medication adherence 
research8. Total overall accuracy of self-reported placebo 
removal was determined through a “pill count” of returned vials 
of raisins and matched nearly identically (97% concordance) in 
all individuals and groups, validating log books as an effective 
tool for adherence analysis in other parts of this study. Whether 
volunteers received text message reminders in the first half 
or second half of the study did not affect adherence rates, 
suggesting no significant trainer effect in this study.
Table 2: Phase Three - Real World Validation
the ability of communication technology to be used as 
a motivator for improving adherence to medications. 
This study is the first, however, to test the use of 
text messages as a mode of reminder for reducing 
forgetfulness. 
Subgroups identified in other studies to be at higher 
risk of non-adherence to medications, such as in 
MacLaughlin et al. (2005), were demonstrated to 
be less adherent to medications in this study. These 
groups were demonstrated to improve more with this 
system, perhaps as a result of their increased risk of 
forgetfulness. Numerous studies such as Wroe et al. 
(2002) have also shown lower adherence rates in less 
educated individuals. This study also demonstrated 
increased rates of improvement in these individuals 
as well. In all groups analyzed, individuals with lower 
baseline adherence rates appeared to benefit most 
from this system.
Additionally, while this system is designed to address 
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Phase Three: 
Table 2 shows the results from the cohort study in Phase 
Three. A high rate of medication non-adherence was noted in 
cardiac patients (17%). This system of text message reminders 
consistently improved adherence to medications, with all 
subjects improving. The average absolute improvement 
was 11%, with a relative risk reduction for non-adherence of 
64%. Certain groups of cardiac patients appeared to have 
lower baseline adherence. The elderly, stroke, dementia, and 
depression patients, as well as those with less education, 
showed lower rates of adherence to medications (Table 3). 
Consistent with other studies, the vast majority of subjects, 
71%, reported that forgetfulness was a main contributor to their 
missed medications (Figure 2). Text message reminders were 
reliably sent from an automated computer program and were 
effective at improving adherence in all groups studied. Whether 
individuals received text message in the first half of the study 
or in the second half of the study did not impact the adherence 
rates significantly in any groups (p>0.05). As a result, no trainer 
effect was noted in cardiac patients.
Subgroup Analysis:
Table 3 illustrates the adherence rates of certain groups 
prospectively selected to be at higher risk of increased 
non-adherence to medications. As has been noted in other 
studies, patients with stroke, depression, dementia, and 
elderly patients were indeed found to be less adherent 
to prescribed medications (on average 74% compared to 
the total study population rate of 83%). Subgroups with 
higher non-adherence rates also appeared to benefit more 
than the overall study population, suggesting this system 
Stratification by Education:
Figure 1 illustrates the improvements of patients stratified 
by education level. Previous studies have noted that less 
education is a predictor for non-adherence to medications. 
It was noted in this study, individuals with fewer years of 
education (having attained 12 or less years or education) 
had lower baseline adherence but also appeared to improve 
adherence more through this text message reminder system 
(an 18% improvement vs. 11% in the total study population).
Reasons for Non-adherence:
Figure 2 shows the participants’ self-perceived reasons for 
non-adherence to their own medications. Forgetfulness 
represented 71% of the reasons identified by the participants 
for non-adherence. Cost, side effects and routine were also 
reasons that participants felt caused them to be non-adherent 
to their medications.
Table 3: Phase Three - Subgroup Analysis
Figure 1:
Improvement in adherence based upon educational level
Figure 2:




All Subjects 83.0% 93.8% <0.01
Stroke 68.2% 88.6% <0.05
Dementia 79.9% 94.2% <0.01
Depression 73.8% 91.8% <0.01
Elderly >65 84.0% 96.1% <0.01
Extreme 
Elderly >80 65.4% 89.5% <0.05
<12 Grade 
Education 75.0% 93.8% <0.01
Grade 12 




85.2% 94.8% < 0.01
may be particularly efficacious in those at highest risk for 
non-adherence (on average 18% absolute improvement 
in adherence to medications compared to the total study 
population improvement of 11%). 
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it seems to have a marked effect on reducing non-
adherence with 100% of stable patients demonstrating 
some degree of improvement in adherence with a 
relative risk reduction for non-adherence of 64% 
for the whole study population. This suggests that 
forgetfulness may be an important mechanism leading 
to medication non-adherence and strategies, such as 
this system, that effectively address forgetfulness, 
may improve adherence to medications. 
LIMITATIONS: 
Not all individuals have cell phones. A preliminary test 
of this program, however, demonstrates that it is able 
to deliver a recorded voice message over landline 
phones which may reduce this limitation. This study 
was conducted with a small group of volunteers. This 
study was short in duration, measuring adherence 
over a few weeks only. A longer study assessing the 
impact of this system in cardiac patients has been 
undertaken. This was a self-reported adherence 
study, although past research has shown this to be 
an effective way to determine adherence9. This study 
only addresses one reason for medication non-
adherence: forgetfulness.
CONCLUSIONS:
This novel text message reminder system 
demonstrated reliability, accurately sending text 
messages to numerous cell phones with different 
cell phone providers without fail. The system proved 
effective in improving adherence to a placebo in 
healthy volunteers, and to medications in cardiac 
patients, over a two month period. In all groups studied, 
this system proved effective at reducing the number 
of missed doses, and seemed to be most effective in 
those groups with lower baseline adherence. 
In the future, a similar automated text message 
reminder system could be used to reduce medication 
non-adherence. The system could be offered 
by hospitals or clinics as a way of reducing non-
adherence to medications. The applicability of the 
system could also be tested in numerous other fields 
to test its effectiveness at reducing non-adherence to 
lifestyle changes, and exercise regimens. Strategies, 
such as this text message reminder system, that 
effectively address forgetfulness, may be expected 
to significantly impact non-adherence and perhaps 
over time, contribute to a reduction in morbidity and 
mortality through greater adherence to appropriate 
medications.
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